RWEBX
Price
$68.28
Change
+$0.40 (+0.59%)
Updated
Jun 12 closing price
Net Assets
218.08B
WCEAX
Price
$18.45
Change
+$0.13 (+0.71%)
Updated
Jun 12 closing price
Net Assets
3.74B
Interact to see
Advertisement

RWEBX vs WCEAX

Header iconRWEBX vs WCEAX Comparison
Open Charts RWEBX vs WCEAXBanner chart's image
RWEBX vs WCEAX Comparison Chart in %
View a ticker or compare two or three
VS
RWEBX vs. WCEAX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWEBX is a Hold and WCEAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 218B vs. WCEAX (3.74B). RWEBX pays higher dividends than WCEAX: RWEBX (0.75) vs WCEAX (0.18). RWEBX was incepted earlier than WCEAX: RWEBX (12 years) vs WCEAX (26 years). RWEBX (1.06) and WCEAX (1.01) have similar cost to investors . RWEBX is a more actively managed with annual turnover of: 29.00 vs. WCEAX (24.00). RWEBX has a lower initial minimum investment than WCEAX: RWEBX (250) vs WCEAX (1000). RWEBX annual gain was more profitable for investors over the last year : 10.45 vs. WCEAX (3.74). RWEBX return over 5 years is better than : 23.20 vs. WCEAX (-2.87).
RWEBXWCEAXRWEBX / WCEAX
Total Expense Ratio1.060.99107%
Annual Report Gross Expense Ratio1.061.01105%
Fund Existence12 years26 years-
Gain YTD5.7047.83273%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets218B3.74B5,835%
Annual Yield % from dividends0.750.18417%
Returns for 1 year10.453.74280%
Returns for 3 years28.3619.88143%
Returns for 5 years23.20-2.87-808%
Returns for 10 years80.6846.38174%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NYAX67.841.51
+2.28%
Nayax Ltd
FUTU97.542.01
+2.10%
Futu Holdings Limited
LGO0.80N/A
N/A
Largo
PRME2.78-0.05
-1.60%
Prime Medicine
BDRX3.03-0.05
-1.69%
Biodexa Pharmaceuticals plc